10.6084/m9.figshare.c.3635498_D1.v1 Kavitha Krishnan Kavitha Krishnan Laura Baglietto Laura Baglietto Carmel Apicella Carmel Apicella Jennifer Stone Jennifer Stone Melissa Southey Melissa Southey Dallas English Dallas English Graham Giles Graham Giles John Hopper John Hopper Additional file 1: of Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study Springer Nature 2016 Mammographic density Breast cancer Detection mode Tumor size 2016-06-18 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Mammographic_density_and_risk_of_breast_cancer_by_mode_of_detection_and_tumor_size_a_case-control_study/4438712 Table S1. Risk of breast cancer for BMI and mammographic measures by detection mode, excluding HRT users. Table S2 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding HRT users. Table S3 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding HRT users. Table S4 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases (and matched controls) diagnosed within 2 years of mammogram. Table S5 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S6 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S7 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S8 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S9 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. (DOCX 61 kb)